Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.
Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations.
Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Companytm, is focused on revolutionizing the growing field of proteomics. The Company's Platinum® line of instruments enables Next-Gen Protein Sequencingtm that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.
LUND, SE / ACCESS Newswire / March 25, 2025 / BioInvent International (STO:BINV) The shareholders of BioInvent International AB (publ), Reg. No 556537-7263, are hereby invited to attend the Annual General Meeting to be held at 4.00 p.m., 29 April...
RevitaLash® Cosmetics, globally recognised for its innovative lash, brow, and hair beautification products, announces an expanded three-year partnership with the UK-based breast cancer charity Future Dreams, that incorporates the funding of a...
March 25, 2025 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced that in 2024 it was the leading applicant in the field of medical technology at the European Patent Office (EPO), filing 594 Medtech...
NaturVet, a leader in pet health and wellness, will debut new product innovations and refreshed branding at Global Pet Expo from March 26-28 in Orlando, Florida. The brand's vet-formulated supplements will be on display at booth 4401, including the...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStoptm for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces that...
AMBOSS, the leading resource for medical education and clinical decision-making in Germany and the US, closes a ?240M financing round with new long-term investors, supporting the exploration of additional international markets and the expansion of...
